Jennifer Ribeiro is a cancer biologist studying ovarian cancer mechanisms and novel targets. She completed her PhD in the Pathobiology program at Brown University in 2014, where she studied the role of the transcription factor TAF4B in ovarian cancer. She continued ovarian cancer research as a post-doctoral fellow at Women & Infants Hospital in the Program in Women's Oncology, focusing on various functions of the ovarian cancer biomarker HE4 in the development and progression of the disease. In 2018, she became Assistant Professor (Research). Her laboratory is currently focused on elucidating novel methods to improve immunotherapy response in ovarian cancer by performing immune profiling of patient tissue and studying the relationship between extracellular matrix and immune response. She also studies the role of a novel target, Septin-2, in ovarian cancer metabolism.